Hystelica

Hystelica’s mission is to understand safe and effective psychedelic use for women, delving into the unique needs and experiences of female users to uncover specific applications and address gender-based disparities.

Hystelica was founded in 2022 by Dr Grace Blest-Hopley, a researcher with a decade of expertise in cannabinoid and psychedelic science and military leadership experience. Hystelica is a social enterprise at the vanguard of this emergent field; with a team of dedicated researchers and advocates, they are committed to collecting and analyzing data that has been overlooked historically, aiming to foster informed decisions regarding psychedelic practices for women.

Recognizing the burgeoning interest in psychedelics for women’s health, Hystelica strives to be the touchstone of scientific guidance and responsible use. This commitment is underscored by the launch of the “Survey of Female Psychedelic Use” in collaborative efforts with King’s College London. This research is a pivotal step in our ongoing journey to support female consumers of psychedelics through rigorous research and evidence-based recommendations.